Last reviewed · How we verify
NCT03450785
Incidence and Risk Factors of Central Line Catheter Related Thrombosis
trial testing ultrasound examination in Central Line Complication in 80 participants. Completed in 8 April 2020.
8 April 2020
Quick facts
| Lead sponsor | Seoul National University Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 80 |
| Start date | 7 March 2018 |
| Primary completion | 8 April 2020 |
| Estimated completion | 8 April 2020 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- ultrasound examination
Conditions studied
- Central Line Complication — all drugs for Central Line Complication →
Sponsor
Seoul National University Hospital
Who can join
Under 6, any sex, with Central Line Complication. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Central venous catheters are frequently used for monitoring haemodynamic status and rapidly delivering fluid therapy during the peri- and postoperative periods. Indwelling central venous catheters are typically used 7-14 days postoperatively for additional monitoring and treatment, but patients may develop asymptomatic catheter-related thrombosis, leading to life-threatening pulmonary embolism and death. Early detection helps to avoid such complications. This prospective observational study investigated the risk factors associated with catheter-related right internal jugular vein thrombosis in pediatric patients. The study enrolled 80 pediatric patients who were scheduled to receive central venous catheter. To detect thrombus formation, Doppler ultrasound examinations from the thyroid cartilage level to the supraclavicular region were used after CVC placement and on each of the following days until the catheter was removed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03450785
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of ultrasound examination
Trials testing the same drug.
- NCT06697392 — Ultrasound-based Artificial Intelligence for Classification of Carpal Tunnel Syndrome · active not recruiting
- NCT06283485 — Real-time Anatomy Recognition Tool Accuracy Research for Ultrasound-guided PENG and Suprainguinal Fascia Iliaca Blocks · withdrawn
- NCT04979494 — Association Between SMA Flow and AGI in Critically Ill Patients · completed
- NCT04288648 — Pelvic Floor Contraction in Different Positions Among Women With and Without Stress Urinary Incontinence · completed
- NCT04183972 — Identification of Interscalene Brachial Plexus on Ultrasonography Using a Deep Neural Network · NA · completed
Other recruiting trials for Central Line Complication
Currently open trials in the same condition.
- NCT06094387 — The Use of Thrombin Generation Assay in Detection of Central Line Related Thrombosis (CRT) in Critically Ill Patients · recruiting
- NCT06187831 — Bleeding Events Before vs After Lowering Departmental Platelet Transfusion Trigger · recruiting
Other Seoul National University Hospital trials
Trials by the same sponsor.
- NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
- NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
- NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
- NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
- NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03450785 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
- Last refreshed: 4 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03450785.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing